Alcacyl Ibu 400
Alcacyl Ibu 400 is a medicine authorised by Swissmedic under authorisation number 70425. The authorisation holder is Hänseler AG. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 05 August 2026 and the authorisation is limited until 04 August 2031. ATC code M01AE01 places the medicine in the group Anti-inflammatory and antirheumatic products.
| Authorisation number | 70425 |
|---|---|
| Name | Alcacyl Ibu 400 |
| Full name | Alcacyl Ibu 400, Pulver zur Herstellung einer Suspension zum Einnehmen |
| Authorisation holder | Hänseler AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | M01AE01 |
| First authorisation | 05 August 2026 |
| Authorisation validity | 04 August 2031 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Alcacyl Ibu 400, Pulver zur Herstellung einer Suspension zum Einnehmen | D | 05 August 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 10 | Beutel | M01AE01 | 07.10.1. | D |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Alcacyl Ibu 400 authorised in Switzerland?
Yes. Alcacyl Ibu 400 is authorised by Swissmedic under authorisation number 70425, data as of 01 September 2026. The authorisation is limited until 04 August 2031.
Which dispensing category does Alcacyl Ibu 400 have?
Alcacyl Ibu 400 is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Alcacyl Ibu 400?
The authorisation holder is Hänseler AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.